As of today (2023-09-29), Jianmin Pharmaceutical Group Co's share price is ¥66.28.
Jianmin Pharmaceutical Group Co's Owner Earnings per Share (TTM) ended in Jun. 2023 was ¥2.77. It's Price-to-Owner-Earnings for today is 23.93.
The historical rank and industry rank for Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings or its related term are showing as below:
SHSE:600976'
s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 17.96 Med: 42.36 Max: 115
Current: 23.75
During the past 13 years, the highest Price-to-Owner-Earnings of Jianmin Pharmaceutical Group Co was 115.00. The lowest was 17.96. And the median was 42.36.
As of today (2023-09-29), Jianmin Pharmaceutical Group Co's share price is ¥66.28.
Jianmin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was ¥3.09. Therefore, Jianmin Pharmaceutical Group Co's PE Ratio for today is 21.45.
As of today (2023-09-29), Jianmin Pharmaceutical Group Co's share price is ¥66.28.
Jianmin Pharmaceutical Group Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥3.09. Therefore, Jianmin Pharmaceutical Group Co's PE Ratio without NRI for today is 21.45.
During the past 13 years, Jianmin Pharmaceutical Group Co's highest PE Ratio without NRI was 79.87. The lowest was 15.72. And the median was 33.27.
Jianmin Pharmaceutical Group Co Price-to-Owner-Earnings Historical Data
The historical data trend for Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Jianmin Pharmaceutical Group Co Annual Data
|
|
Trend |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
| Price-to-Owner-Earnings |
|
|
|
|
|
|
41.63 |
44.54 |
35.41 |
45.55 |
21.18 |
|
Jianmin Pharmaceutical Group Co Quarterly Data
|
|
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
| Price-to-Owner-Earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.27 |
17.96 |
21.18 |
31.74 |
27.80 |
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jianmin Pharmaceutical Group Co Price-to-Owner-Earnings Distribution
For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings falls in comparison to its industry or sector. The grey bar indicates the Price-to-Owner-Earnings's extreme value range as defined by GuruFocus.
Jianmin Pharmaceutical Group Co Price-to-Owner-Earnings Calculation
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Jianmin Pharmaceutical Group Co's Price-to-Owner-Earnings for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianmin Pharmaceutical Group Co (SHSE:600976) Business Description
Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Jianmin Pharmaceutical Group Co (SHSE:600976) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
66.28 
(1.98%) Volume: 1,858,900 Sep. 28
Email Alerts
Stock PDF
RSS
Website
Sources
Download
Manual of Stocks™ Web APP
SHSE:600976 has been successfully added to your